The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 25, 2014
Filed:
Jun. 28, 2013
Applicant:
Otsuka Pharmaceutical Factory, Inc., Tokushima, JP;
Inventors:
Irina Neagu, Plainsboro, NJ (US);
Michael Ohlmeyer, Plainsboro, NJ (US);
Vidyadhar M. Paradkar, Somerville, NJ (US);
Kurt W. Saionz, Cranford, NJ (US);
Koushi Iwata, Tokushima, JP;
Takashi Okamura, Tokushima, JP;
Tadao Shibutani, Tokushima, JP;
Assignee:
Otsuka Pharmaceutical Factory, Inc., Naruto-shi, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/415 (2006.01); A61K 31/425 (2006.01); A61K 31/519 (2006.01); A61K 31/4164 (2006.01); A61K 31/4184 (2006.01); A61K 31/4188 (2006.01); A61K 31/428 (2006.01); A61K 31/4745 (2006.01); C07D 233/58 (2006.01); C07D 235/18 (2006.01); C07D 277/66 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); C07D 513/04 (2006.01); A61K 31/429 (2006.01); A61K 31/437 (2006.01); C07D 233/56 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); C07D 233/56 (2013.01); A61K 31/4164 (2013.01); A61K 31/4184 (2013.01); A61K 31/4188 (2013.01); A61K 31/428 (2013.01); A61K 31/4745 (2013.01); C07D 233/58 (2013.01); C07D 235/18 (2013.01); C07D 277/66 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 513/04 (2013.01); A61K 31/429 (2013.01); A61K 31/437 (2013.01);
Abstract
The present invention provides pharmaceutical compositions containing benzene compound(s) represented by General Formula (1) below and, particularly, LPL-activating compositions for use in hyperlipidemia therapeutic and preventive agents, anti-obesity agents, and the like: wherein R, R, Rand Rare as defined in the specification.